Monocyte chemoattractant protein-1 predicts the development of diabetic nephropathy.
Florian G ScurtJan MenneSabine BrandtAnja BernhardtPeter R MertensHermann HallerChristos ChatzikyrkouPublished in: Diabetes/metabolism research and reviews (2021)
MCP-1 is a marker and possibly a mediator of early diabetic nephropathy. Further prospective studies are necessary to test whether diabetic patients with elevated MCP-1 levels would benefit from specific therapeutic interventions.